Review of Management and Outcomes in Women with Thrombophilia Risk during Pregnancy at a Single Institution

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Types of anticoagulant</td><td align="center">Number of cases</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Aspirin</td><td align="center">6</td></tr><tr><td align="left">Warfarin</td><td align="center">1</td></tr><tr><td align="left">Enoxaparin</td><td align="center">18</td></tr><tr><td align="left">Folic acid</td><td align="center">1</td></tr><tr><td align="left">Enoxaparin + aspirin</td><td align="center">8</td></tr><tr><td align="left">Enoxaparin + folic acid</td><td align="center">1</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Type of anticoagulant used in pregnancy. 

International Scholarly Research Notices

tab3

Table 3

Table 3: Review of Management and Outcomes in Women with Thrombophilia Risk during Pregnancy at a Single Institution 